Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

How Does Semaglutide Work to Lose Weight?

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for obesity and type 2 diabetes management.

Diabetes and Periodontitis

What is HbA1C Testing?

Vitamin D and Type 2 Diabetes

Treatment and Prognosis for Diabetic Mastopathy

Diabetic Neuropathy Symptoms

History of Diabetes

Pins and Needles and Diabetes

Research into a Cure for Diabetes

What Causes Diabetes?

What is Diabetic Retinopathy?

Effects of Hyperglycemia on the Vascular System

See more featured articles »

Causes of Foot Pain

Diabetic Retinopathy Treatments

Diabetes and Mucormycosis

Walking After Meals: Small Habit, Big Metabolic Gains

How Baking Soda Affects People with Type 2 Diabetes

Diabetic Retinopathy Diagnosis

Diabetic Coma Severe Hypoglycemia

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Diabetic Neuropathy Diagnosis

Nonketotic Hyperosmolar Coma

Hypoglycemic Unawareness

Diabetic Mastopathy: Complication of Diabetes Mellitus

Adiponectin and Diabetes

What is Diabetes?

Genetic Testing for Diabetes

How does Gestational Diabetes Affect the Baby?

Diabetes Symptoms

Diabetes Screening

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

The Impact of Glucagon on Diabetes Management

What is HbA1c?

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Diabetic Retinopathy Risk Factors

What Causes Diabetic Nephropathy (Kidney Disease)?

Epigenetic Mechanisms in Type 2 Diabetes

Diabetic Hypoglycemia Treatments

The Risks of Prediabetes

Diabetic Coma Treatments

Diabetic Nephropathy Symptoms

Artificial Pancreas Systems: The Future of Diabetes Management?

Diabetes Diagnosis

Diabetes Management

What is Diabetic Hypoglycemia?

Diabetic Mastopathy Diagnosis

Supplements for Diabetes

What is Diabetic Ketoacidosis?

Diabetic Hypoglycemia Etiology

COVID-19 and Diabetes

Diabetes Risk Factors

Diabetic Retinopathy Symptoms

Diabetes and Skin Problems

Diabetes Complications

Diabetic Foot Problems

Diabetic Neuropathy Treatments

What is Diabetic Nephropathy?

Diabetes and Vision

Is a Plant-Based Diet Good for Type 2 Diabetes?

What are Nightmares and Why Do They Occur?

Diabetes in Men

Diabetes and Wound Healing

Alcohol and Diabetes

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Animals That Can Detect Hypoglycemia

Encapsulating Islet Cells for the Treatment of Diabetes

Diabetes and Pregnancy

Does the Keto Diet Increase the Risk of Diabetes?

Advanced Diabetic Ketoacidosis

Can I reverse my prediabetes naturally

What is Diabetic Neuropathy?

Diabetes in Men versus Women

Red Blood Cell Morphology Changes in Diabetes

Diabetes Pathophysiology

Understanding MODY 5: A Rare Genetic Form of Diabetes

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Diabetic Ketoacidosis Causes

Diabetic Emergencies: What to Do

Diabetic Neuropathy Pathogenesis

The Future of Diabetes Treatment

Diabetes Types

Risks to Infants of Diabetic Mothers

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Cause of Diabetic Coma

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

What is a Diabetic Coma?

Low Sugar Foods for Diabetes

Diabetes and Sleep

Diabetic Nephropathy Treatment

Latest Diabetes News and Research

Study points to a surprising new ally in the fight against type 2 diabetes

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation - and pointing to a surprising new ally in the fight against type 2 diabetes.

19 Sep 2025

UNM researcher develops new model for characterizing different forms of vascular dementia

Vascular dementia - cognitive impairment caused by disease in the brain's small blood vessels - is a widespread problem, but it has not been as thoroughly studied as Alzheimer's disease, in which abnormal plaques and protein tangles are deposited in neural tissue.

19 Sep 2025

Replacing red meat with legumes improves heart health and supports weight management

A University of Helsinki study found that partially replacing red and processed meat with pea- and faba bean–based foods resulted in reduced total and 'bad' LDL cholesterol levels in men, along with weight loss.

19 Sep 2025

New study warns of millions of undiagnosed and missing people with type 1 diabetes

The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates, according to the results of a new modeling study being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept).

19 Sep 2025

Oral drug baricitinib shows promise in slowing early type 1 diabetes progression

In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial [1] reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the body's own insulin production and slow the progression of type 1 diabetes (T1D) in people recently diagnosed with the condition.

19 Sep 2025

WHO's new report highlights the urgent need to address NCDs and mental health

The World Health Organization (WHO) today released a new report titled "Saving lives, spending less", revealing that an additional investment of just US$3 per person annually in tackling noncommunicable diseases (NCDs) could yield economic benefits of up to US$1 trillion by 2030.

19 Sep 2025

Can eating style affect how well GLP-1 drugs control diabetes and weight?

Research indicates that external eating behavior is a key predictor of weight loss in type 2 diabetes patients receiving GLP-1 receptor agonists.

19 Sep 2025

New findings support low-dose ATG to delay progression of type 1 diabetes

New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.

19 Sep 2025

Verapamil shows potential for preserving beta-cell function in type 1 diabetes

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil (360mg daily) could have a potential effect on beta-cell function in adults with newly diagnosed type 1 diabetes.

18 Sep 2025

Hyperemesis gravidarum associated with increased neuropsychiatric disorders in pregnancy

The largest study on pregnant women with excessive nausea and vomiting (hyperemesis gravidarum) has identified increased risks of numerous neuropsychiatric and mental health outcomes.

18 Sep 2025

Oral GLP-1 drug orforglipron achieves significant weight loss in global trial

Patients taking an experimental oral GLP-1 drug lost significant weight and improved their heart and metabolic risk factors in a large, international, phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions

18 Sep 2025

New trial demonstrates efficacy of tirzepatide in children and adolescents with type 2 diabetes

New research shows that that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10-17 years whose diabetes and weight are inadequately controlled with an existing treatment regimen of metformin, insulin, or both.

18 Sep 2025

Climate change is already driving heat mortality and massive economic losses

Researchers systematically identified just 20 studies directly linking human-driven climate change to specific health impacts and deaths worldwide. They estimate tens of billions in annual economic losses and warn of inequities in research leadership and data coverage.

18 Sep 2025

AI model maps lifetime disease risks to transform future healthcare planning

Researchers developed Delphi-2M, a transformer-based AI trained on UK Biobank and Danish health data to predict and simulate lifetime trajectories for 1,256 diseases. It accurately forecasted long-term multimorbidity risks, generated synthetic health records, and highlighted comorbidity patterns while exposing key biases.

18 Sep 2025

PANoptosis emerges as a promising strategy against liver cancer

Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers, driven by high recurrence and resistance to therapy.

18 Sep 2025

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

Evening meals hold the key to morning glucose control in prediabetes

The way glucose is regulated at night plays a key role in fasting glucose levels the next morning, when blood sugar is expected to be at its lowest.

18 Sep 2025

Cholesterol control improves but cardiovascular disease still increases in Mexico

Despite improved statin use and cholesterol control, cardiovascular disease risk rose in Mexico between 2016 and 2023, according to a study being presented at ACC Latin America 2025 that used region-specific tools to more accurately predict the local disease burden.

18 Sep 2025

Health care cuts threaten homegrown solutions to rural doctor shortages

Olivia Owlett chose to do her primary care residency in this Northern California college town largely because it faces many of the same health care challenges she grew up with.

18 Sep 2025

Mediterranean diet may protect gums by reducing severe periodontitis

This study reveals that the Mediterranean diet may protect against periodontitis, highlighting its benefits for oral health and inflammation reduction.

18 Sep 2025